1 Global Pelvic Floor Electrical Stimulation Devices Market Size (Value) and CAGR (2024-2033)
In 2024, the global Pelvic Floor Electrical Stimulation Devices market was valued at USD 174.19 million, with a CAGR of 10.2% from 2024 to 2033.
Electrical stimulation of pelvic floor is a painless and effective method to treat urinary incontinence, frequent micturition and urgency. Pelvic floor electrical stimulation devices are usually used for patients with frequent urination, urgency or urinary incontinence due to overactive bladder. It is also used to help women with weak vaginal muscle tension strengthen the pelvic floor.
In the process of pelvic floor electrical stimulation, low-grade electrical current stimulates muscle contraction, and produces muscle response similar to Kegels (pelvic floor muscle exercise). This exercise can strengthen pelvic floor muscles, thus improving frequent urination, urgency and urinary incontinence, and increasing the strength of pelvic floor and vaginal muscles.
Figure Global Pelvic Floor Electrical Stimulation Devices Market Size (M USD) and CAGR 2024-2033
2 Pelvic Floor Electrical Stimulation Devices Market Drivers
The Pelvic Floor Electrical Stimulation Devices market is experiencing significant growth, driven by several key factors. One of the primary drivers is the increasing incidence of urinary incontinence and other pelvic floor disorders. These conditions affect a large portion of the population, particularly women, and their prevalence is expected to rise with an aging global population. The effectiveness of pelvic floor electrical stimulation devices in treating these conditions has led to higher adoption rates among healthcare providers and patients.
Another significant driver is the growing awareness of pelvic health and the benefits of non-invasive treatments. Electrical stimulation devices offer a non-surgical, drug-free alternative that is both convenient and effective, making them an attractive option for many patients. The increasing availability of these devices through over-the-counter channels and their ease of use in home care settings further enhance their appeal.
Technological advancements have also played a crucial role in the market’s growth. Innovations in wearable technology, such as the INNOVO device by Atlantic Therapeutics, have made pelvic floor stimulation more accessible and user-friendly. These devices provide clinically proven solutions that can be easily integrated into daily routines, contributing to their widespread acceptance.
3 Pelvic Floor Electrical Stimulation Devices Market Restraints
Despite the growth drivers, the Pelvic Floor Electrical Stimulation Devices market faces several challenges and restraints. One of the main challenges is the competition from alternative treatments. Biofeedback training therapy and magnetic stimulation therapy, for example, offer similar benefits and compete for market share. These alternative therapies may be preferred by some patients and healthcare providers, limiting the growth potential of electrical stimulation devices.
Economic and political uncertainties also pose significant challenges. Trade tensions and geopolitical issues can disrupt supply chains and increase costs for manufacturers.
Another restraint is the relatively low industry concentration, with no single company holding a dominant market share. This fragmented market structure can lead to intense competition, making it difficult for individual companies to achieve economies of scale and maintain high profit margins.
4 Global Pelvic Floor Electrical Stimulation Devices Market Size by Type in 2024
Mobile Pelvic Floor Electrical Stimulation Devices are designed for portability and ease of use, making them ideal for home care settings. These devices are particularly popular among patients who require regular treatment but prefer the convenience of using the device in the comfort of their homes. According to the latest market research, the production of Mobile devices in 2024 is forecasted to reach 673.5 thousand units. This segment dominates the market, accounting for approximately 97.15% of the total production. The high demand for Mobile devices can be attributed to their user-friendly design, which allows for easy self-administration of treatment without the need for professional assistance.
Fixed Pelvic Floor Electrical Stimulation Devices, on the other hand, are typically larger and more complex, designed for use in clinical settings such as hospitals and specialized clinics. These devices are often used for more severe cases or when professional supervision is required. In 2024, the production of Fixed devices is expected to be around 19.7 thousand units, representing about 2.85% of the total market production. While Fixed devices have a smaller market share, they play a crucial role in providing advanced treatment options for patients with more complex conditions.
Table Global Pelvic Floor Electrical Stimulation Devices Market Production by Type in 2024
Type | Market Production (K Units) 2024 | Market Share 2024 |
Mobile | 673.5 | 97.15% |
Fixed | 19.7 | 2.85% |
5 Global Pelvic Floor Electrical Stimulation Devices Market Size by Application in 2024
Hospitals are a significant application segment for Pelvic Floor Electrical Stimulation Devices, primarily due to their role in providing specialized medical care and advanced treatment options. In 2024, hospitals are expected to account for approximately 182.6 thousand units of production. These devices are used in hospitals for treating patients with severe pelvic floor disorders, often in conjunction with other diagnostic and therapeutic procedures. The high investment capacity and advanced medical infrastructure in hospitals support the adoption of these devices, making them an essential part of patient care.
Clinics, including outpatient and specialized clinics, represent another important application segment. In 2024, clinics are projected to account for around 144.1 thousand units of production. These devices are used in clinics for routine treatments and follow-up care, offering a more accessible and cost-effective option compared to hospitals. The growing number of specialized clinics focusing on pelvic health and the increasing demand for non-invasive treatments drive the market for Pelvic Floor Electrical Stimulation Devices in this segment.
Home care settings represent the largest application segment, driven by the convenience and accessibility of mobile devices. In 2024, home care settings are expected to account for approximately 315.2 thousand units of production. Mobile devices designed for home use allow patients to receive treatment in the comfort of their homes, reducing the need for frequent hospital or clinic visits. This segment is particularly popular among patients with mild to moderate conditions who prefer self-administered therapy.
Table Global Pelvic Floor Electrical Stimulation Devices Market Production by Application in 2024
Application | Market Production (K Units) 2024 | Market Share 2024 |
Hospitals | 182.6 | 26.34% |
Clinics | 144.1 | 20.79% |
Home Care Settings | 315.2 | 45.47% |
Others | 51.3 | 7.40% |
6 Global Pelvic Floor Electrical Stimulation Devices Market Size by Region in 2024
North America is the largest market for Pelvic Floor Electrical Stimulation Devices, driven by advanced healthcare infrastructure, high awareness levels, and a large aging population. In 2024, North America is projected to account for approximately 279.7 thousand units of production. The United States, in particular, plays a significant role in this market, with a high adoption rate of advanced medical technologies.
Europe is the second-largest market, characterized by a strong healthcare system and a growing demand for non-invasive treatments. In 2024, Europe is expected to account for around 246.3 thousand units of production. The market in Europe is driven by increasing awareness of pelvic health and the availability of reimbursement policies that support the use of these devices.
China represents a rapidly growing market for Pelvic Floor Electrical Stimulation Devices, driven by increasing healthcare spending and a growing aging population. In 2024, China is projected to account for approximately 95.5 thousand units of production. The market in China is expected to expand significantly in the coming years, supported by government initiatives to improve healthcare infrastructure and increase access to advanced medical technologies.
Figure Global Pelvic Floor Electrical Stimulation Devices Market Size by Region in 2024
7 Major Players in Global Pelvic Floor Electrical Stimulation Devices Market
7.1 Laborie, Inc.
Company Profile:
Laborie, Inc. is a leading global developer, manufacturer, and marketer of innovative medical technology and consumables used for the diagnosis and treatment of pelvic health in the fields of Urology, Gynecology, and Colorectal care. Established in 1967, Laborie has a strong presence in the United States and serves a global market. The company is known for its comprehensive pelvic floor rehabilitation systems, which include advanced features such as EMG-Uroflow protocols and customizable treatment programs.
Business Overview:
Laborie’s business is centered around providing high-quality medical devices that improve patient outcomes in pelvic health. Their products are designed to be user-friendly and effective, catering to both clinical and home care settings. The company’s recent acquisition of Clinical Innovations has further expanded its portfolio, making it a leader in medical devices for labor and delivery as well as neonatal intensive care.
Product Introduction:
Laborie’s pelvic floor electrical stimulation devices include clinic-based systems that offer comprehensive capabilities such as automatic muscle fatigue point calculation and simultaneous EMG-Uroflowmetry studies. These devices are designed to improve the strength and function of pelvic floor muscles, addressing issues like urinary incontinence and fecal incontinence.
Revenue and Gross Margin Data:
In the most recent year, Laborie, Inc. reported a revenue of 11.33 million USD with a gross margin of 32.99%.
7.2 Zynex Medical
Company Profile:
Zynex Medical, established in 1996, is a leading provider of electrotherapy products designed to improve the quality of life for patients suffering from debilitating pain or illness. The company specializes in creating high-quality, non-invasive devices that offer effective pain management and rehabilitation solutions. Zynex Medical has a strong presence in the United States and serves a global market.
Business Overview:
Zynex Medical’s mission is to provide the highest technology and service standards in the electrotherapy industry. Their products are designed to be portable, easy to use, and effective in managing various health conditions, including urinary incontinence. The company’s focus on innovation and customer satisfaction has helped it establish a strong reputation in the market.
Product Introduction:
Zynex Medical’s pelvic floor electrical stimulation devices, such as the InWave, offer nonsurgical, drug-free therapy for managing incontinence. These devices feature multiple programmed modes, a large illuminated display, and a built-in treatment timer, making them user-friendly and effective for home use.
Revenue and Gross Margin Data:
In the most recent year, Zynex Medical reported a revenue of 7.87 million USD with a gross margin of 32.20%.
7.3 TensCare Ltd.
Company Profile:
TensCare Ltd., founded in 1994, is Europe’s largest manufacturer and distributor of TENS machines. The company specializes in providing drug-free pain relief solutions for chronic pain conditions and offers a range of electrotherapy devices for muscle rehabilitation and pelvic floor exercises. TensCare is known for its innovative and user-friendly products, which are designed to improve the quality of life for patients.
Business Overview:
TensCare’s business is centered around providing effective and accessible solutions for pain management and muscle rehabilitation. Their products are designed to be easy to use, making them suitable for both clinical and home care settings. The company’s focus on innovation and customer satisfaction has helped it establish a strong presence in the European market and beyond.
Product Introduction:
TensCare’s pelvic floor electrical stimulation devices, such as the Kegel Toner, offer effective solutions for improving continence and relieving bladder weaknesses. These devices feature preset programs, adjustable intensity settings, and safety features to ensure effective and safe use.
Revenue and Gross Margin Data:
In the most recent year, TensCare Ltd. reported a revenue of 6.80 million USD with a gross margin of 29.69%.